Pilot Study of Nicotine Nasal Spray and Varenicline on Smoking in Methadone-Maintained Patients
A Pilot Randomized, Placebo-Controlled, Crossover Study of the Effect of the Nicotine Nasal Spray and Varenicline on Cigarette Smoking Following Methadone Dosing in Methadone-Maintained Patients
Sponsor: University of Cincinnati
Terminated
Difficulty recruiting eligible participants; study medication was expiring.
Other terminated trials from University of Cincinnati
Other Cigarette Smoking trials with similar outcome
Listed as NCT02147132, this PHASE4 trial focuses on Cigarette Smoking and Methadone Maintenance and remains terminated or withdrawn. Sponsored by University of Cincinnati, it has been updated 11 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE4
-
Jan 2019 — Jan 2021 [monthly]
Terminated PHASE4
▶ Show 6 earlier versions
-
Jun 2018 — Jan 2019 [monthly]
Terminated PHASE4
-
May 2018 — Jun 2018 [monthly]
Terminated PHASE4
-
Jan 2018 — May 2018 [monthly]
Terminated PHASE4
Status: Enrolling By Invitation → Terminated
-
Jun 2017 — Jan 2018 [monthly]
Enrolling By Invitation PHASE4
-
Feb 2017 — Jun 2017 [monthly]
Enrolling By Invitation PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Enrolling By Invitation PHASE4
First recorded
Mar 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Cincinnati
For direct contact, visit the study record on ClinicalTrials.gov .